Topiramate
-
Subject Areas on Research
- Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia.
- Angle-closure glaucoma associated with ciliary body detachment in patients using topiramate.
- Bilateral angle closure following use of a weight loss combination agent containing topiramate.
- Combination phentermine and topiramate extended release in the management of obesity.
- Genetic and environmental correlates of topiramate-induced cognitive impairment.
- Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
- JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk.
- Long-term patterns of weight changes during topiramate therapy: an observational study.
- Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
- Potential neuroprotective effects of continuous topiramate therapy in the developing brain.
- Topiramate for the prophylaxis of episodic migraine in adults.
- Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
- Topiramate-induced confusion following a single ingestion of 400 mg.
- Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.